Drinking baking soda for weight loss is not backed by solid scienceand carries more risks than most viral videos let on
In clinical use, BPC-157 may support healing in patients whose activities, occupations, or injuries require additional metabolic support
Factors : Location, provider, frequency
Alternatively, they may be deficient in B12 for other reasons
But important limitations exist: Most research is in animals, not humans Long-term safety beyond 12 weeks is uncharacterized Drug interactions haven't been formally studied Cancer relationship remains unclear Who should consider BPC-157: Those researching recovery support for injuries or gut issues Individuals willing to accept calculated risk with an experimental peptide People who can work with a knowledgeable healthcare provider Who should avoid it: Those with active cancer or high cancer risk Anyone on medications that might interact (especially cardiovascular, dopamine-affecting) Individuals unwilling to monitor their response carefully If you choose to use BPC-157, start conservatively (200 mcg daily), use proper injection technique, source from reputable suppliers, and track your body's response